Recombinant Human JMJD1C Protein，His

JMJD1C (Jumonji domain-containing protein 1C) is a member of the Jumonji C (JmjC) domain-containing family of proteins, which play critical roles in the regulation of gene expression through histone demethylation. Research has identified JMJD1C as a crucial player in various biological processes, including embryonic development, cellular differentiation, and response to environmental stress. It specifically targets methylated histones, particularly trimethylated lysine 9 on histone H3 (H3K9me3), thereby influencing chromatin structure and gene accessibility. Dysregulation of JMJD1C has been linked to several diseases, including cancer and metabolic disorders, making it an important target for therapeutic interventions. Recent studies have focused on the biochemical characterization of JMJD1C to elucidate its enzymatic activity and substrate specificity, as well as its interaction with other regulatory proteins. By understanding the function and regulation of JMJD1C at the molecular level, researchers aim to uncover its potential as a biomarker or therapeutic target in various pathological conditions, further highlighting the necessity for the development of recombinant JMJD1C protein for in vitro and in vivo studies. The production and study of this recombinant protein facilitate the exploration of its demethylase activity and functional roles in epigenetic regulation, providing insights into the broader implications of histone modifications in cellular biology.